Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Vasculitis Drugs on Complement System in Children
NCT03692416Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Nov 2018
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of ibuprofen, prednisone, methylprednisolone and methotrexate in vasculitis (3 arms), sponsored by Assiut University. Primary endpoint: Serum levels of C3, C4 & C5a at 2 years. Status: unknown.
02
Drugs
ibuprofenprednisonemethylprednisolonemethotrexate
03
Conditions
vasculitis
Beyond the preview
Go deeper on NCT03692416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03692416.